Search citation statements
Paper Sections
Citation Types
Year Published
Publication Types
Relationship
Authors
Journals
Hyperfibrinolysis, hepatotoxicity and lack of efficacy: case reportA 47-year-old man developed hyperfibrinolysis and hepatotoxicity during treatment with ciprofloxacin. Additionally, he exhibited lack of efficacy during treatment with vitamin K for hyperfibrinolysis.The man, who had alcoholic cirrhosis, presented to the emergency department with right groin pain. He had been receiving ciprofloxacin [route and dosage not stated] for K.oxytoca and P. rettgeri bacteremia. On admission a physical examination showed tenderness of the right groin with passive and active range-of-motion, right groin haematoma and diffuse petechiae. CT scans of abdomen and pelvis showed moderate ascites and retroperitoneal haematoma secondary to psoas tear centering near the distal right psoas. His INR was >27.0 [duration of treatment to reaction onset not stated].Then, the man received vitamin K [route and dosage not stated]; however, it failed to improve coagulopathy in setting of worsening anemia. Later, he was treated with vitamin K, unspecified cryoprecipitates and fresh frozen plasma. Additional studies showed undetectable fibrinogen, increased D-dimer and increased INR. These findings were consistent with hyperfibrinolysis related to ciprofloxacin. Subsequently, he was treated with aminocaproic acid [e-aminocaproic acid]. Eventually, a transient improvement in coagulopathy was noted. Later, he experienced worsening coagulopathy. He was discharged on hospice and died after 72 hours [an exact cause of death not stated]. Later, it was confirmed that his hepatotoxicity was associated with ciprofloxacin.Schubert LR, et al. Hyperfibrinolysis in the setting of retroperitoneal hematoma secondary to psoas tear in patient with decompensated liver cirrhosis and possible hepatotoxicity from ciprofloxacin.
Hyperfibrinolysis, hepatotoxicity and lack of efficacy: case reportA 47-year-old man developed hyperfibrinolysis and hepatotoxicity during treatment with ciprofloxacin. Additionally, he exhibited lack of efficacy during treatment with vitamin K for hyperfibrinolysis.The man, who had alcoholic cirrhosis, presented to the emergency department with right groin pain. He had been receiving ciprofloxacin [route and dosage not stated] for K.oxytoca and P. rettgeri bacteremia. On admission a physical examination showed tenderness of the right groin with passive and active range-of-motion, right groin haematoma and diffuse petechiae. CT scans of abdomen and pelvis showed moderate ascites and retroperitoneal haematoma secondary to psoas tear centering near the distal right psoas. His INR was >27.0 [duration of treatment to reaction onset not stated].Then, the man received vitamin K [route and dosage not stated]; however, it failed to improve coagulopathy in setting of worsening anemia. Later, he was treated with vitamin K, unspecified cryoprecipitates and fresh frozen plasma. Additional studies showed undetectable fibrinogen, increased D-dimer and increased INR. These findings were consistent with hyperfibrinolysis related to ciprofloxacin. Subsequently, he was treated with aminocaproic acid [e-aminocaproic acid]. Eventually, a transient improvement in coagulopathy was noted. Later, he experienced worsening coagulopathy. He was discharged on hospice and died after 72 hours [an exact cause of death not stated]. Later, it was confirmed that his hepatotoxicity was associated with ciprofloxacin.Schubert LR, et al. Hyperfibrinolysis in the setting of retroperitoneal hematoma secondary to psoas tear in patient with decompensated liver cirrhosis and possible hepatotoxicity from ciprofloxacin.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.